Q4 2025 earnings call recap: revenue growth, 2026 guidance, Category 1 CPT impact, and BENEFIT-HF trial upside—read key takeaways.

Sensus Healthcare (NASDAQ:SRTS) used its fourth-quarter and full-year 2025 earnings call to emphasize a major regulatory and ...

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological ...

Fourth quarter revenue growth of 12% and full year revenue growth of 14%Fourth quarter net income per diluted share of $4.66; adjusted net income ...

CVRx, Inc. (NASDAQ: CVRX) ('CVRx'), a commercial-stage medical device company focused on developing, manufacturing and ...

Inspire Medical Systems, Inc. (NYSE:INSP) Q4 2025 Earnings Call Transcript February 11, 2026 Inspire Medical Systems, Inc.

Research Solutions, Inc. , the leading AI-powered research workflow platform, reported financial results for its fiscal ...

Artivion, Inc. , a leading cardiac and vascular surgery company focused on aortic disease, today announced financial results for the fourth quarter and year ended December 31, ...

After seven years of developing the mental health artificial intelligence for providers and payers and investing in ...

Baird cut the stock to “neutral,” saying recent reimbursement developments have clouded visibility into future utilization and new account growth. The brokerage said it is harder to justify a higher ...

Inspire Medical Systems, Inc. is a Sell due to competitive pressures, reimbursement uncertainties & margin compression. Read ...

Families and business with tax debts “excluded from state storm support”: Further cracks appear in government’s ‘pledges’ ...